Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 5 September 2024, 17:35 HKT/SGT
Share:

Source: Fenbo Holdings Limited
Fenbo Holdings Limited Plans to Raise $5 Million Via New Share Sale

HONG KONG, Sept 5, 2024 - (ACN Newswire) - Fenbo Holdings Limited, an established original equipment manufacturer (OEM) that produces electrical hair styling products under the "Remington" brand, seeks to raise as much as $5 million by selling new shares via a follow-on deal after its initial public offering late last year, according to a company filing in August.

Fenbo intends to use approximately 20% of the net proceeds to bolster its research efforts on developing new products; approximately 40% of the net proceeds to develop its own branded products; approximately 30% to form an expanded sales team for marketing its own branded products; and approximately 10% for general working capital, according to the filing.

Headquartered in Hong Kong, Fenbo represents over 30 years of experience producing personal care electric appliances (principally electrical hair styling products) and toys products to overseas markets. The company, since 2006 also has been served as an OEM and ODM for Spectrum Brands, a global home essential company, and its sole customer, producing electrical hair styling products, under the "Remington" brand which Spectrum Brands has the right of the use of, and which are currently sold to Europe, United States and Latin America, according to its website.

About Fenbo Industries Ltd.

Fenbo Industries Ltd. is a Hong Kong based company with over 30 years of experience in producing exceptional household electric appliances and toys products. We specialize in producing a large variety of final goods, which we supply to many department stores and leading companies worldwide. We also provide in OEM and ODM projects and total solutions for our worldwide clients.For more information, visit https://www.fenbo.com/landing.htm.

 

 

 

 

 

 




Topic: Press release summary
Source: Fenbo Holdings Limited

Sectors: Electronics, Beauty & Skin Care
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets  
Feb 6, 2026 17:45 HKT/SGT
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share  
Feb 6, 2026 17:01 HKT/SGT
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization  
Feb 6, 2026 16:34 HKT/SGT
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis  
Feb 6, 2026 14:17 HKT/SGT
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025  
Feb 6, 2026 13:13 HKT/SGT
Mitsubishi Motors Launches the All-New Versa Van in the Philippine Market  
Friday, February 6, 2026 12:34:00 PM
Eternal Beauty Holdings Limited and Lane Crawford Debut Landmark Fragrance, Further Expanding Footprint in High-Margin Niche Fragrance Market  
Feb 6, 2026 12:21 HKT/SGT
Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors  
Feb 6, 2026 11:44 HKT/SGT
Establishment of the World's First*1 Global Supply Chain to Introduce the Use of Renewable Plastics in Sony's High-Performance Products  
Friday, February 6, 2026 10:50:00 AM
Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan  
Friday, February 6, 2026 10:31:00 AM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: